September 8, 2025 · Form 4 insider transaction
Schwartz Jonathan David bought 80,000 shares of Rocket Pharmaceuticals Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.; Represent RSUs that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on September 8, 2026, with the remaining shares vesting in equal quarterly installments over the following two years.